Prime Medicine (PRME) Income Statement: Revenue & Earnings

Prime Medicine Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Prime Medicine, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	2.98	0.17	0.29	0.00	5.21
Cost of Revenue	155.29	147.91	86.73	70.55	2.98
Gross Profit	-152.31	0.17	-86.73	-70.55	2.23
Operating Expenses
Research & Development	155.29	147.91	86.73	70.55	0.00
Selling, General & Administrative	50.16	43.39	29.82	13.92	3.16
Operating Expenses	205.45	204.79	29.82	13.92	3.16
Operating Income	-202.47	-204.79	-116.54	-84.47	-0.93
Other Income/Expense
Interest Income	3.52	2.81	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	3.06	-5.95	1.90	-80.99	-11.48
Income
Income Before Tax	-195.88	-182.53	-122.77	-165.85	-1.54
Income Tax Expense	0.00	-0.28	-0.95	-0.49	1.87
Net Income	-195.88	-198.13	-121.82	-165.37	-3.41
Net Income - Continuous Operations	-195.88	-198.13	-121.82	-165.37	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-196.34	-184.38	-114.32	-83.91	-0.89
EBIT	-202.47	-198.41	-116.54	-84.47	-0.93
Depreciation & Amortization	6.13	4.65	2.22	0.57	0.04
Earnings Per Share
Basic EPS	-2.00	-2.00	-4.00	-14.00	-2.00
Diluted EPS	-2.00	-2.00	-4.00	-14.00	-2.00
Basic Shares Outstanding	118.60	90.97	33.89	12.97	2.64
Diluted Shares Outstanding	118.60	90.97	33.89	12.97	2.64